SNOA (Sonoma Pharmaceuticals, Inc. Common Stock) Stock Analysis - Analyst Ratings

Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is a publicly traded Healthcare sector company. As of May 21, 2026, SNOA trades at $1.13 with a market cap of $3.58M and a P/E ratio of -0.38. SNOA moved +4.46% today. Year to date, SNOA is -71.31%; over the trailing twelve months it is -67.48%. Its 52-week range spans $0.85 to $6.92. Rallies surfaces SNOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SNOA?

The average price target is $0.00.

SNOA Key Metrics

Key financial metrics for SNOA
MetricValue
Price$1.13
Market Cap$3.58M
P/E Ratio-0.38
EPS$-2.79
Dividend Yield0.00%
52-Week High$6.92
52-Week Low$0.85
Volume2.76K
Avg Volume0
Revenue (TTM)$14.29M
Net Income$-2.91M
Gross Margin38.25%

SNOA Analyst Consensus

SNOA analyst coverage data. Average price target: $0.00.

Latest SNOA News

Common questions about SNOA

What do analysts rate SNOA?
The average price target is $0.00.
Does Rallies show SNOA price targets?
Yes. Rallies tracks SNOA analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SNOA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SNOA. It does not provide personalized investment advice.
SNOA

SNOA